Human Gene CPSF2 (uc001yah.2)
  Description: Homo sapiens cleavage and polyadenylation specific factor 2, 100kDa (CPSF2), mRNA.
Transcript (Including UTRs)
   Position: hg19 chr14:92,588,298-92,630,543 Size: 42,246 Total Exon Count: 16 Strand: +
Coding Region
   Position: hg19 chr14:92,597,329-92,628,088 Size: 30,760 Coding Exon Count: 14 

Page IndexSequence and LinksUniProtKB CommentsPrimersGenetic AssociationsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated at UCSC: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr14:92,588,298-92,630,543)mRNA (may differ from genome)Protein (782 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
GeneNetworkH-INVHGNCHPRDLynxMGI
neXtProtOMIMPubMedReactomeTreefamUniProtKB
WikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: CPSF2_HUMAN
DESCRIPTION: RecName: Full=Cleavage and polyadenylation specificity factor subunit 2; AltName: Full=Cleavage and polyadenylation specificity factor 100 kDa subunit; Short=CPSF 100 kDa subunit;
FUNCTION: Component of the cleavage and polyadenylation specificity factor (CPSF) complex that play a key role in pre-mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. Involved in the histone 3' end pre-mRNA processing.
SUBUNIT: Component of the cleavage and polyadenylation specificity factor (CPSF) complex, composed of CPSF1, CPSF2, CPSF3, CPSF4 and FIP1L1. Interacts with CPSF3, CSTF2 and SYMPK.
SUBCELLULAR LOCATION: Nucleus (Potential).
SIMILARITY: Belongs to the metallo-beta-lactamase superfamily. RNA-metabolizing metallo-beta-lactamase-like family. CPSF2/YSH1 subfamily.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): CPSF2
CDC HuGE Published Literature: CPSF2
Positive Disease Associations: Cholesterol, LDL , Diabetes Mellitus, Type 2 , Eye Color , Hair Color , height , Hip , Iris
Related Studies:
  1. Cholesterol, LDL
    Sekar Kathiresan et al. BMC medical genetics 2007, A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study., BMC medical genetics. [PubMed 17903299]
    Using a 100K genome-wide scan, we have generated a set of putative associations for common sequence variants and lipid phenotypes. Validation of selected hypotheses in additional samples did not identify any new loci underlying variability in blood lipids. Lack of replication may be due to inadequate statistical power to detect modest quantitative trait locus effects (i.e., <1% of trait variance explained) or reduced genomic coverage of the 100K array. GWAS in FHS using a denser genome-wide genotyping platform and a better-powered replication strategy may identify novel loci underlying blood lipids.
  2. Diabetes Mellitus, Type 2
    Mariana Murea et al. American journal of nephrology 2011, Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes., American journal of nephrology. [PubMed 21546767]
    Genetic variation may modify the risk of death on dialysis. SNPs in proximity to genes regulating vascular extracellular matrix, cardiac ventricular repolarization, and smoking cessation are associated with dialysis survival in AAs with T2D. These results warrant replication in other cohorts and races.
  3. Eye Color
    Patrick Sulem et al. Nature genetics 2007, Genetic determinants of hair, eye and skin pigmentation in Europeans., Nature genetics. [PubMed 17952075]
           more ... click here to view the complete list

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 16.46 RPKM in Cells - EBV-transformed lymphocytes
Total median expression: 358.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -92.20268-0.344 Picture PostScript Text
3' UTR -667.992455-0.272 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR001279 - Beta-lactamas-like
IPR022712 - Beta_Casp
IPR025069 - Cpsf2_C
IPR011108 - RMMBL

Pfam Domains:
PF00753 - Metallo-beta-lactamase superfamily
PF07521 - Zn-dependent metallo-hydrolase RNA specificity domain
PF10996 - Beta-Casp domain
PF13299 - Cleavage and polyadenylation factor 2 C-terminal
PF16661 - Metallo-beta-lactamase superfamily domain

SCOP Domains:
56281 - Metallo-hydrolase/oxidoreductase

ModBase Predicted Comparative 3D Structure on Q9P2I0
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologGenome BrowserGenome BrowserGenome BrowserNo ortholog
Gene Details  Gene DetailsGene Details 
Gene Sorter  Gene SorterGene Sorter 
  EnsemblFlyBaseWormBase 
  Protein SequenceProtein SequenceProtein Sequence 
  AlignmentAlignmentAlignment 

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0003723 RNA binding
GO:0005515 protein binding

Biological Process:
GO:0000398 mRNA splicing, via spliceosome
GO:0006369 termination of RNA polymerase II transcription
GO:0006378 mRNA polyadenylation
GO:0006379 mRNA cleavage
GO:0006397 mRNA processing
GO:0006398 mRNA 3'-end processing by stem-loop binding and cleavage
GO:0006406 mRNA export from nucleus
GO:0031124 mRNA 3'-end processing

Cellular Component:
GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005847 mRNA cleavage and polyadenylation specificity factor complex
GO:0016020 membrane


-  Descriptions from all associated GenBank mRNAs
  BC060854 - Homo sapiens cDNA clone IMAGE:5298171, containing frame-shift errors.
AK001912 - Homo sapiens cDNA FLJ11050 fis, clone PLACE1004564, highly similar to Cleavage and polyadenylation specificity factor 100 kDa subunit.
BC070095 - Homo sapiens cleavage and polyadenylation specific factor 2, 100kDa, mRNA (cDNA clone MGC:87517 IMAGE:5267724), complete cds.
AK001627 - Homo sapiens cDNA FLJ10765 fis, A-NT2RP4000111, highly similar to Cleavage and polyadenylation specificity factor 100 kDa subunit.
JD269749 - Sequence 250773 from Patent EP1572962.
JD061248 - Sequence 42272 from Patent EP1572962.
JD394994 - Sequence 376018 from Patent EP1572962.
JD240473 - Sequence 221497 from Patent EP1572962.
JD287636 - Sequence 268660 from Patent EP1572962.
JD511361 - Sequence 492385 from Patent EP1572962.
KJ898964 - Synthetic construct Homo sapiens clone ccsbBroadEn_08358 CPSF2 gene, encodes complete protein.
AK023583 - Homo sapiens cDNA FLJ13521 fis, clone PLACE1005876, highly similar to Cleavage and polyadenylation specificity factor 100 kDa subunit.
AB037788 - Homo sapiens mRNA for KIAA1367 protein, partial cds.
AL442079 - Homo sapiens mRNA; cDNA DKFZp667D133 (from clone DKFZp667D133).
JD270231 - Sequence 251255 from Patent EP1572962.
JD565932 - Sequence 546956 from Patent EP1572962.
JD094388 - Sequence 75412 from Patent EP1572962.
JD170714 - Sequence 151738 from Patent EP1572962.
JD038397 - Sequence 19421 from Patent EP1572962.
JD106754 - Sequence 87778 from Patent EP1572962.
JD501464 - Sequence 482488 from Patent EP1572962.
JD093434 - Sequence 74458 from Patent EP1572962.
JD237415 - Sequence 218439 from Patent EP1572962.
JD549166 - Sequence 530190 from Patent EP1572962.
JD552155 - Sequence 533179 from Patent EP1572962.
JD410768 - Sequence 391792 from Patent EP1572962.
JD113093 - Sequence 94117 from Patent EP1572962.
JD288644 - Sequence 269668 from Patent EP1572962.
JD112570 - Sequence 93594 from Patent EP1572962.
JD355446 - Sequence 336470 from Patent EP1572962.
JD369091 - Sequence 350115 from Patent EP1572962.
JD066423 - Sequence 47447 from Patent EP1572962.
JD513602 - Sequence 494626 from Patent EP1572962.
JD119370 - Sequence 100394 from Patent EP1572962.
JD454165 - Sequence 435189 from Patent EP1572962.
JD359573 - Sequence 340597 from Patent EP1572962.
JD542847 - Sequence 523871 from Patent EP1572962.
JD212857 - Sequence 193881 from Patent EP1572962.
JD322338 - Sequence 303362 from Patent EP1572962.
JD069934 - Sequence 50958 from Patent EP1572962.
JD397253 - Sequence 378277 from Patent EP1572962.
JD308120 - Sequence 289144 from Patent EP1572962.
JD435417 - Sequence 416441 from Patent EP1572962.
JD254595 - Sequence 235619 from Patent EP1572962.
JD264489 - Sequence 245513 from Patent EP1572962.
JD264490 - Sequence 245514 from Patent EP1572962.
JD272884 - Sequence 253908 from Patent EP1572962.
JD496362 - Sequence 477386 from Patent EP1572962.
JD324066 - Sequence 305090 from Patent EP1572962.
JD295287 - Sequence 276311 from Patent EP1572962.
JD480776 - Sequence 461800 from Patent EP1572962.
JD470491 - Sequence 451515 from Patent EP1572962.
JD239853 - Sequence 220877 from Patent EP1572962.
JD248635 - Sequence 229659 from Patent EP1572962.
JD321638 - Sequence 302662 from Patent EP1572962.
JD356465 - Sequence 337489 from Patent EP1572962.
JD505948 - Sequence 486972 from Patent EP1572962.
JD404009 - Sequence 385033 from Patent EP1572962.
JD460186 - Sequence 441210 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  BioCarta from NCI Cancer Genome Anatomy Project
h_cpsfPathway - Polyadenylation of mRNA

Reactome (by CSHL, EBI, and GO)

Protein Q9P2I0 (Reactome details) participates in the following event(s):

R-HSA-72231 Cleavage and Polyadenylation
R-HSA-77589 Recognition of AAUAAA sequence by CPSF
R-HSA-72185 mRNA polyadenylation
R-HSA-77594 Docking of the Mature intronless derived transcript derived mRNA, TAP and Aly/Ref at the NPC
R-HSA-72130 Formation of an intermediate Spliceosomal C (Bact) complex
R-HSA-72180 Cleavage of mRNA at the 3'-end
R-HSA-77590 Recruitment of CstF to the CPSF Bound Pre-mRNA
R-HSA-77592 Cleavage of Intronless Pre-mRNA at 3'-end
R-HSA-77593 Cleavage and polyadenylation of Intronless Pre-mRNA
R-HSA-72143 Lariat Formation and 5'-Splice Site Cleavage
R-HSA-72139 Formation of the active Spliceosomal C (B*) complex
R-HSA-8849157 TREX complex binds spliced, capped mRNA:CBC:EJC cotranscriptionally
R-HSA-156661 Formation of Exon Junction Complex
R-HSA-77591 Binding of Cleavage factors and Poly(A)Polymerase to the CstF:CPSF:Pre-mRNA Complex
R-HSA-72163 mRNA Splicing - Major Pathway
R-HSA-77595 Processing of Intronless Pre-mRNAs
R-HSA-72187 mRNA 3'-end processing
R-HSA-159231 Transport of Mature mRNA Derived from an Intronless Transcript
R-HSA-109688 Cleavage of Growing Transcript in the Termination Region
R-HSA-72172 mRNA Splicing
R-HSA-75067 Processing of Capped Intronless Pre-mRNA
R-HSA-72203 Processing of Capped Intron-Containing Pre-mRNA
R-HSA-159234 Transport of Mature mRNAs Derived from Intronless Transcripts
R-HSA-73856 RNA Polymerase II Transcription Termination
R-HSA-8953854 Metabolism of RNA
R-HSA-72202 Transport of Mature Transcript to Cytoplasm
R-HSA-73857 RNA Polymerase II Transcription
R-HSA-74160 Gene expression (Transcription)

-  Other Names for This Gene
  Alternate Gene Symbols: B3KME1, CPSF100, CPSF2_HUMAN, KIAA1367, NM_017437, NP_059133, Q6NSJ1, Q9H3W7, Q9P2I0
UCSC ID: uc001yah.2
RefSeq Accession: NM_017437
Protein: Q9P2I0 (aka CPSF2_HUMAN or CPSB_HUMAN)
CCDS: CCDS9902.1

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: NM_017437.2
exon count: 16CDS single in 3' UTR: no RNA size: 5072
ORF size: 2349CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 4844.00frame shift in genome: no % Coverage: 100.00
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.